BiondVax is developing an innovative flu vaccine that will provide universal multi-season/multi-strain protection against most human influenza virus strains, as well as the Avian flu.

BiondVax’s proprietary technology utilizes a combination of conserved epitopes from influenza virus proteins to activate the immune system for a cross-protecting and long-lasting effect.